STERIS plc (STE)
NYSE: STE · Real-Time Price · USD
247.07
+3.31 (1.36%)
At close: Aug 13, 2025, 4:00 PM
247.07
0.00 (0.00%)
After-hours: Aug 13, 2025, 7:00 PM EDT
STERIS Revenue
STERIS had revenue of $1.39B in the quarter ending June 30, 2025, with 8.72% growth. This brings the company's revenue in the last twelve months to $5.57B, up 6.42% year-over-year. In the fiscal year ending March 31, 2025, STERIS had annual revenue of $5.46B with 6.24% growth.
Revenue (ttm)
$5.57B
Revenue Growth
+6.42%
P/S Ratio
4.37
Revenue / Employee
$313,213
Employees
17,787
Market Cap
24.33B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 5.46B | 320.81M | 6.24% |
| Mar 31, 2024 | 5.14B | 602.44M | 13.28% |
| Mar 31, 2023 | 4.54B | 312.86M | 7.41% |
| Mar 31, 2022 | 4.22B | 1.12B | 35.91% |
| Mar 31, 2021 | 3.11B | 76.62M | 2.53% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
STE News
- 6 days ago - STERIS plc (STE) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 7 days ago - STERIS Announces Chief Financial Officer Transition - GlobeNewsWire
- 7 days ago - STERIS Announces Financial Results for Fiscal 2026 First Quarter - GlobeNewsWire
- 14 days ago - STERIS Raises Dividend to $0.63 per share - GlobeNewsWire
- 22 days ago - STERIS to Host a Conference Call for Fiscal 2026 First Quarter Results on August 7, 2025 - GlobeNewsWire
- 3 months ago - U.S. Gynecological Chairs and Tables Market Size, Share & Trends Analysis Report 2025-2030 Featuring STERIS, The Brewer Company, Midmark Corp. (Ritter Midmark), Clinton Industries, UMF Medical and More - GlobeNewsWire
- 3 months ago - Steris: May Benefit From Bringing Pharmaceutical Manufacturing Back To The U.S. - Seeking Alpha
- 3 months ago - STERIS plc (STE) Q4 2025 Earnings Call Transcript - Seeking Alpha